| Literature DB >> 28441357 |
Imke F Wulsten1, Thais A Costa-Silva2, Juliana T Mesquita3, Marta L Lima4,5, Mariana K Galuppo6, Noemi N Taniwaki7, Samanta E T Borborema8, Fernando B Da Costa9, Thomas J Schmidt10, Andre G Tempone11.
Abstract
Leishmaniases are neglected infectious diseases caused by parasites of the 'protozoan' genus Leishmania. Depending on the parasite species, different clinical forms are known as cutaneous, muco-cutaneous, and the visceral leishmaniasis (VL). VL is particularly fatal and the therapy presents limitations. In the search for new anti-leishmanial hit compounds, seven natural sesquiterpene lactones were evaluated against promastigotes and intracellular amastigotes of Leishmania (Leishmania) infantum, a pathogen causing VL. The pseudoguaianolides mexicanin I and helenalin acetate demonstrated the highest selectivity and potency against intracellular amastigotes. In addition, promastigotes treated with helenalin acetate were subject to an ultrastructural and biochemical investigation. The lethal action of the compound was investigated by fluorescence-activated cell sorting and related techniques to detect alterations in reactive oxygen species (ROS) content, plasma membrane permeability, and mitochondrial membrane potential. Helenalin acetate significantly reduced the mitochondrial membrane potential and the mitochondrial structural damage was also confirmed by transmission electron microscopy, displaying an intense organelle swelling. No alteration of plasma membrane permeability or ROS content could be detected. Additionally, helenalin acetate significantly increased the production of nitric oxide in peritoneal macrophages, probably potentiating the activity against the intracellular amastigotes. Helenalin acetate could hence be a useful anti-leishmanial scaffold for further optimization studies.Entities:
Keywords: Leishmania (L.) infantum; drugs; helenalin acetate; mexicanin I; nitric oxide; pseudoguaianolides; sesquiterpene lactones
Mesh:
Substances:
Year: 2017 PMID: 28441357 PMCID: PMC6154613 DOI: 10.3390/molecules22050685
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of the tested sesquiterpene lactones (STLs). (1) Helenalin acetate; (2) Mexicanin I; (3) Arglabin; (4) Cynaropicrin; (5) Alantolactone; (6) Parthenolide; (7) Budlein A.
In vitro antileishmanial activity and mammalian cytotoxicity of sesquiterpene lactones (STLs).
| Compounds | Cytotoxicity | SI (NCTC/Amastigote) | ||
|---|---|---|---|---|
| IC50 (μM) (SD) | IC50 (μM) (SD) | CC50 (μM) (SD) | ||
| Helenalin acetate ( | 3.53 (0.2) | 1.15 (0.22) | 8.12 (1.47) | 7.0 |
| Mexicanin I ( | 4.89 (1.2) | 1.73 (0.7) | 9.20 (2.74) | 5.3 |
| Arglabin ( | 29.98 (2.4) | 7.33 (4.0) | 39.35 (6.38) | 5.3 |
| Cynaropicrin ( | 30.59 (0.61) | 6.88 (3.5) | 33.54 (7.39) | 4.8 |
| Alantolactone ( | 9.94 (0.14) | n.a. | 11.04 (1.61) | - |
| Parthenolide ( | 59.13 (4.00) | 89.20 (-) | 58.18 (9.14) | <1 |
| Budlein A ( | 28.00 (7.87) | n.a. | 9.05 (1.86) | - |
| Miltefosine | 16.69 (3.49) | 17.80 (1.39) | 116.70 (5.30) | 6.5 |
IC50: 50% inhibitory concentration; CC50: 50% cytotoxic concentration; n.a.: not active to the highest concentration of 100 μM; SI: selectivity index based on CC50 in murine fibroblasts (NCTC)/IC50 in amastigotes.
Figure 2Permeability of L. (L.) infantum plasma membrane incubated with compound 1 assessed spectrofluorimetrically by the fluorescence of the SYTOX Green. Promastigotes were treated with 1 (3 and 6 μM) for 60 min. At the end of this treatment, Triton X-100 was used for 100% permeabilization. Dimethyl sulfoxide (DMSO) was used as internal control and did not cause any alteration in membrane permeability (data not shown).
Figure 3(a) Depolarization of the mitochondrial membrane potential (Δψm) and (b) production of reactive oxygen species (ROS) of L. (L.) infantum promastigotes treated with compound 1 for 1 h. (a) Promastigotes were treated with 1 (6 μM) and then stained with rhodamine 123 (0.3 μg/mL) or (b) H2DCFDA (5 μM). Data were normalized to the intensity of Rd123 fluorescence achieved in non-depolarized untreated promastigotes (a) or H2DCFDA fluorescence achieved in promastigotes treated with oligomycin (b). In both cases, fluorescence was measured in 10,000 cells using a FL1 at 530 ± 15 nm on a Flow Cytometer Attune Nxt. Error bars depict the mean and standard deviation (SD) of duplicate samples. For each assay, one representative of two independently performed experiments is shown. n.s, not significant; *** indicates significant differences with the control at p < 0.001; ** indicates p < 0.01.
Figure 4Transmission electron microscopy imaging of L. (L.) infantum promastigotes treated with helenalin acetate (1). 2 × 107 promastigotes/well were incubated with 1 for different periods of time. (a) Untreated control. (b) 0.5 h; (c) 1 h; (d) 2 h; (e,f) 3 h; (g) 4 h. The figure shows representative images taken from one out of two independent experiment. The observed ultrastructural observations appeared consistently in both independent Transmission Electron Microscopy (TEM) experiments.
Figure 5Production of nitric oxide (NO) by peritoneal macrophages of BALB/c mice treated with helenalin acetate (1). The production of NO was determined colorimetrically by the Griess assay. The data were blanked and normalized to the value of control cells (untreated macrophages); 1 × 105 macrophages/well were incubated with (1) at 3 μM for 24 h. Untreated = Untreated macrophages; lipopolysaccharide (LPS) = 5 μg/mL lipopolysaccharide (positive control); Hel ac = helenalin acetate (1). Error bars depict the mean and SD of duplicate samples. *** α = 0.001. One representative of two independently performed experiments is shown.